
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Iranian strikes on Israel injure 11 and set chemical plant ablaze - 2
Geminid meteor shower 2025 peaks next week. Here's what you need to know about this year's best meteor shower - 3
'Harmonious' meeting between Merz, Lula despite Belém controversy - 4
Find the Specialty of Calligraphy: Dominating the Exquisite Art of Penmanship - 5
Cruising Solo All over the Planet: An Excursion of Self-Disclosure
My Excursion to Monetary Autonomy: Awesome ways to save cash
The Most Paramount Crossroads in Olympic History
Dental Embed Innovation: An Achievement in Helpful Dentistry
Figure out How to Assess the Unwavering quality of SUVs for Seniors
Nexi expands alliance with PayPal
I took my shoes off and went for a barefoot hike. I couldn’t believe what happened next
The Best Games Crossroads in History
Trying to improve your health and wellness in 2026? Keep it simple
Which camera do you believe is great for first-time clients? !













